Cargando…
Preparative immunotherapy with anti-OX40 and anti-CTLA4 improves the response to chemotherapy
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292427/ http://dx.doi.org/10.1186/2051-1426-2-S3-P207 |
_version_ | 1782352482679128064 |
---|---|
author | Friedman, David J Young, Kristina Baird, Jason R Cottam, Benjamin Savage, Talicia Newell, Pippa Kasiewicz, Melissa Redmond, William Curti, Brendan Crocenzi, Todd Gough, Michael J Crittenden, Marka |
author_facet | Friedman, David J Young, Kristina Baird, Jason R Cottam, Benjamin Savage, Talicia Newell, Pippa Kasiewicz, Melissa Redmond, William Curti, Brendan Crocenzi, Todd Gough, Michael J Crittenden, Marka |
author_sort | Friedman, David J |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4292427 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42924272015-01-15 Preparative immunotherapy with anti-OX40 and anti-CTLA4 improves the response to chemotherapy Friedman, David J Young, Kristina Baird, Jason R Cottam, Benjamin Savage, Talicia Newell, Pippa Kasiewicz, Melissa Redmond, William Curti, Brendan Crocenzi, Todd Gough, Michael J Crittenden, Marka J Immunother Cancer Poster Presentation BioMed Central 2014-11-06 /pmc/articles/PMC4292427/ http://dx.doi.org/10.1186/2051-1426-2-S3-P207 Text en Copyright © 2014 Friedman et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Poster Presentation Friedman, David J Young, Kristina Baird, Jason R Cottam, Benjamin Savage, Talicia Newell, Pippa Kasiewicz, Melissa Redmond, William Curti, Brendan Crocenzi, Todd Gough, Michael J Crittenden, Marka Preparative immunotherapy with anti-OX40 and anti-CTLA4 improves the response to chemotherapy |
title | Preparative immunotherapy with anti-OX40 and anti-CTLA4 improves the response to chemotherapy |
title_full | Preparative immunotherapy with anti-OX40 and anti-CTLA4 improves the response to chemotherapy |
title_fullStr | Preparative immunotherapy with anti-OX40 and anti-CTLA4 improves the response to chemotherapy |
title_full_unstemmed | Preparative immunotherapy with anti-OX40 and anti-CTLA4 improves the response to chemotherapy |
title_short | Preparative immunotherapy with anti-OX40 and anti-CTLA4 improves the response to chemotherapy |
title_sort | preparative immunotherapy with anti-ox40 and anti-ctla4 improves the response to chemotherapy |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292427/ http://dx.doi.org/10.1186/2051-1426-2-S3-P207 |
work_keys_str_mv | AT friedmandavidj preparativeimmunotherapywithantiox40andantictla4improvestheresponsetochemotherapy AT youngkristina preparativeimmunotherapywithantiox40andantictla4improvestheresponsetochemotherapy AT bairdjasonr preparativeimmunotherapywithantiox40andantictla4improvestheresponsetochemotherapy AT cottambenjamin preparativeimmunotherapywithantiox40andantictla4improvestheresponsetochemotherapy AT savagetalicia preparativeimmunotherapywithantiox40andantictla4improvestheresponsetochemotherapy AT newellpippa preparativeimmunotherapywithantiox40andantictla4improvestheresponsetochemotherapy AT kasiewiczmelissa preparativeimmunotherapywithantiox40andantictla4improvestheresponsetochemotherapy AT redmondwilliam preparativeimmunotherapywithantiox40andantictla4improvestheresponsetochemotherapy AT curtibrendan preparativeimmunotherapywithantiox40andantictla4improvestheresponsetochemotherapy AT crocenzitodd preparativeimmunotherapywithantiox40andantictla4improvestheresponsetochemotherapy AT goughmichaelj preparativeimmunotherapywithantiox40andantictla4improvestheresponsetochemotherapy AT crittendenmarka preparativeimmunotherapywithantiox40andantictla4improvestheresponsetochemotherapy |